Kolon Life Science

Developer of cell theapies, oncolytic viruses,and active pharmaceutical ingredients

placeSeoul, Seoul, South Korea calendar_todayFounded 2006 groups451 employees language kolonls.co.kr

Innovation

77 patent families (12 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 663 times.

YearFilings
20152
20164
20176
20188
201910
20209
202112
202210
20239
20248
20253
20262

Investor mix

2 investors on record.

Investor typeCountShare
Private equity2100%
Coming soon